TRDA logo

Entrada Therapeutics, Inc. Common Stock


TRDA: Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.


Show TRDA Financials

Consumer Interest
SEC Filings

Recent trades of TRDA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by TRDA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Cell penetrating peptides and methods of making and using thereof Jan. 18, 2022
  • Patent Title: Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy Nov. 09, 2021
  • Patent Title: Cell penetrating peptides and methods of making and using thereof Oct. 27, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of TRDA in WallStreetBets Daily Discussion


Recent insights relating to TRDA

CNBC Recommendations

Recent picks made for TRDA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TRDA

Corporate Flights

Flights by private jets registered to TRDA